[ Price : $8.95]
FDA places a clinical hold on a Sigilon Therapeutics Phase 1/2 study of SIG-001 in patients with severe or moderately severe hemop...[ Price : $8.95]
FDA approves Bayers Kerendia (finerenone) tablets to reduce the risk of kidney function decline, kidney failure, cardiovascular de...[ Price : $8.95]
FDA grants full approval to Astellas Pharma for Padcev (enfortumab vedotin-ejfv), a Nectin-4-directed antibody and microtubule inh...[ Price : $8.95]
Federal Register notice: HHS withdraws a 1/21 notice entitled Requests for Proposals for Insulin Reimportation and Personal Prescr...[ Price : $8.95]
FDA says manufacturers of non-sterile water-based drugs should take steps to guard against contamination from Burkholderia cepacia...[ Price : $8.95]
Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Novartis Piqray (alpelisib)...[ Price : $8.95]
FDA approves a Biogen labeling amendment that narrows the indication for its controversial Alzheimers therapy Aduhelm (aducanumab)...[ Price : $8.95]
FDA alerts health care providers about potential biocompatibility concerns associated with NuVasive Specialized Orthopedics Precic...